This document summarizes Brian Bot's presentation on biomedical research in an increasingly digital world. It discusses how biomedical data is increasingly being produced, aggregated, and shared digitally. Only a small percentage of studies can be fully reproduced due to issues with data availability and documentation. However, organizations like Sage Bionetworks are working to promote open sharing of complex biological data through diverse collaborations and by empowering citizens to contribute their own health data to research. One example is the mPower study on Parkinson's disease which has involved thousands of participants sharing passive and active data through mobile apps.
2016 Data Commons and Data Science Workshop June 7th and June 8th 2016. Genomic Data Commons, FAIR, NCI and making data more findable, publicly accessible, interoperable (machine readable), reusable and support recognition and attribution
May 2016 NCI Cancer Center Directors meeting. Data Sharing and the Cancer Genomic Data Commons (GDC). Focus is on cancer genomic and clinical phenotype data.
DOE-NCI Pilots presentation at the Frederick National Laboratory Advisory Com...Warren Kibbe
May 2016 FNLAC presentation of the DOE-NCI partnership around three pilots focused on existing projects in NCI and existing NSCI directives and activities in DOE.
dkNET Webinar: Creating and Sustaining a FAIR Biomedical Data Ecosystem 10/09...dkNET
Abstract
In this presentation, Susan Gregurick, Ph.D., Associate Director of Data Science and Director, Office of Data Science Strategy at the National Institutes of Health, will share the NIH’s vision for a modernized, integrated FAIR biomedical data ecosystem and the strategic roadmap that NIH is following to achieve this vision. Dr. Gregurick will highlight projects being implemented by team members across the NIH’s 27 institutes and centers and will ways that industry, academia, and other communities can help NIH enable a FAIR data ecosystem. Finally, she will weave in how this strategy is being leveraged to address the COVID-19 pandemic.
Presenter: Susan Gregurick, Ph.D., Associate Director of Data Science and Director, Office of Data Science Strategy at the National Institutes of Health
dkNET Webinar Information: https://dknet.org/about/webinar
NCI Cancer Genomics, Open Science and PMI: FAIR Warren Kibbe
Talk given to the NLM Fellows on July 8, 2016. Touches on Cancer Genomics, Open Science and PMI: FAIR in NCI genomics thinking and projects. Includes discussion of the Genomic Data Commons (GDC), Cancer Data Ecosystem, Data sharing, and the NCI cancer clinical trials open API.
160929 teamscope presentation molecule to businessSMBBV
Teamscope; mHealth, a paradigm shift in clinical reseach. Presentation by Diego Mechaca during 'From Molecule to Business' event by SMB Life Sciences and Health Valley at NovioTechCampus, Nijmegen, The Netherlands on September 29, 2016.
Funding agencies are instituting requirements for data management and sharing as a condition of receiving research funds. This presentation addresses why researchers should care about research data management, what libraries have to do with it, and a case study of what one research specialist at the University of Colorado Anschutz Medical Campus is doing in this area.
Digital Scholar Webinar: Clinicaltrials.gov Registration and Reporting DocumentsSC CTSI at USC and CHLA
This 60-minute webinar covers the basic requirements for registration and results reporting requirements in Clinicaltrials.gov. Tips and tricks will be provided, as well as the most common issues to avoid to ensure a smooth and efficient process for public posting and updates to clinical studies. Learning Objectives At the conclusion of this webinar, participants will be able to identify internal contacts and resources available to assist with their Clinicaltrials.gov registration or results reporting.
Participant-centered research design and “equal access” data sharing practice...Jason Bobe
Topics include:
What is "equal access" to data?
How have the roles of human subjects expanded over time?
Where has equal access to data been a success?
What are the barriers to equal access in research?
From Deadly E. coli to Endangered Polar Bear: GigaScience Provides First Cita...GigaScience, BGI Hong Kong
Slides from GigaScience press-conference at BGI's Bio-IT APAC meeting on the GigaScience website launch and release of first unpublished animal genomes released from database. Genomes include polar bear, penguin, pigeon and macaque. 6th July 2011
How to avoid Random Association Syndrome: Getting value from Big Health Data.Tracy Allison Altman
My presentation at Big Data Science meetup May 25. The Big Picture for Big Health Data. Differences between big health data and others, sources of big health data and uses for it, analytical methods, algorithms/prize competitions, and opportunities for data scientists.
2016 Data Commons and Data Science Workshop June 7th and June 8th 2016. Genomic Data Commons, FAIR, NCI and making data more findable, publicly accessible, interoperable (machine readable), reusable and support recognition and attribution
May 2016 NCI Cancer Center Directors meeting. Data Sharing and the Cancer Genomic Data Commons (GDC). Focus is on cancer genomic and clinical phenotype data.
DOE-NCI Pilots presentation at the Frederick National Laboratory Advisory Com...Warren Kibbe
May 2016 FNLAC presentation of the DOE-NCI partnership around three pilots focused on existing projects in NCI and existing NSCI directives and activities in DOE.
dkNET Webinar: Creating and Sustaining a FAIR Biomedical Data Ecosystem 10/09...dkNET
Abstract
In this presentation, Susan Gregurick, Ph.D., Associate Director of Data Science and Director, Office of Data Science Strategy at the National Institutes of Health, will share the NIH’s vision for a modernized, integrated FAIR biomedical data ecosystem and the strategic roadmap that NIH is following to achieve this vision. Dr. Gregurick will highlight projects being implemented by team members across the NIH’s 27 institutes and centers and will ways that industry, academia, and other communities can help NIH enable a FAIR data ecosystem. Finally, she will weave in how this strategy is being leveraged to address the COVID-19 pandemic.
Presenter: Susan Gregurick, Ph.D., Associate Director of Data Science and Director, Office of Data Science Strategy at the National Institutes of Health
dkNET Webinar Information: https://dknet.org/about/webinar
NCI Cancer Genomics, Open Science and PMI: FAIR Warren Kibbe
Talk given to the NLM Fellows on July 8, 2016. Touches on Cancer Genomics, Open Science and PMI: FAIR in NCI genomics thinking and projects. Includes discussion of the Genomic Data Commons (GDC), Cancer Data Ecosystem, Data sharing, and the NCI cancer clinical trials open API.
160929 teamscope presentation molecule to businessSMBBV
Teamscope; mHealth, a paradigm shift in clinical reseach. Presentation by Diego Mechaca during 'From Molecule to Business' event by SMB Life Sciences and Health Valley at NovioTechCampus, Nijmegen, The Netherlands on September 29, 2016.
Funding agencies are instituting requirements for data management and sharing as a condition of receiving research funds. This presentation addresses why researchers should care about research data management, what libraries have to do with it, and a case study of what one research specialist at the University of Colorado Anschutz Medical Campus is doing in this area.
Digital Scholar Webinar: Clinicaltrials.gov Registration and Reporting DocumentsSC CTSI at USC and CHLA
This 60-minute webinar covers the basic requirements for registration and results reporting requirements in Clinicaltrials.gov. Tips and tricks will be provided, as well as the most common issues to avoid to ensure a smooth and efficient process for public posting and updates to clinical studies. Learning Objectives At the conclusion of this webinar, participants will be able to identify internal contacts and resources available to assist with their Clinicaltrials.gov registration or results reporting.
Participant-centered research design and “equal access” data sharing practice...Jason Bobe
Topics include:
What is "equal access" to data?
How have the roles of human subjects expanded over time?
Where has equal access to data been a success?
What are the barriers to equal access in research?
From Deadly E. coli to Endangered Polar Bear: GigaScience Provides First Cita...GigaScience, BGI Hong Kong
Slides from GigaScience press-conference at BGI's Bio-IT APAC meeting on the GigaScience website launch and release of first unpublished animal genomes released from database. Genomes include polar bear, penguin, pigeon and macaque. 6th July 2011
How to avoid Random Association Syndrome: Getting value from Big Health Data.Tracy Allison Altman
My presentation at Big Data Science meetup May 25. The Big Picture for Big Health Data. Differences between big health data and others, sources of big health data and uses for it, analytical methods, algorithms/prize competitions, and opportunities for data scientists.
Part of the "2016 Annual Conference: Big Data, Health Law, and Bioethics" held at Harvard Law School on May 6, 2016.
This conference aimed to: (1) identify the various ways in which law and ethics intersect with the use of big data in health care and health research, particularly in the United States; (2) understand the way U.S. law (and potentially other legal systems) currently promotes or stands as an obstacle to these potential uses; (3) determine what might be learned from the legal and ethical treatment of uses of big data in other sectors and countries; and (4) examine potential solutions (industry best practices, common law, legislative, executive, domestic and international) for better use of big data in health care and health research in the U.S.
The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School 2016 annual conference was organized in collaboration with the Berkman Center for Internet & Society at Harvard University and the Health Ethics and Policy Lab, University of Zurich.
Learn more at http://petrieflom.law.harvard.edu/events/details/2016-annual-conference.
Big-Data in Health Care: Patient data analyses has great potential and risksDr. Jonathan Mall
Big-Data potential in Health care and daily practical work of doctors, nurses and health care professionals. Through self tracking, social media & text analysis (Facebook, Twitter, LinkedIn, Xing, Gmail etc.), insights can be extracted into a persons risk factors, personality, interests and social context. Helping doctors to make better decisions based on fine grained data.
Presentation covers basics of Big Data & its potential uses in healthcare. Data is growing & moving faster day by day. Getting access to this valuable data & factoring it into clinical & advanced analytics is critical to improve care. So there must be analysis of big data to make effective decisions.
These slides use concepts from my (Jeff Funk) course entitled analyzing hi-tech opportunities to analyze how Big Data is becoming economically feasible for health care. These slides describe how the cost of sensors, data processing, data storage and data analyzing are falling, how new and better forms of storage and algorithms are being implemented, and what this means for sustainable health care. These changes are enabling a move towards personalized health care.
Законодательство и оценка рисков при автоматизации работы с документами. Вызо...Natasha Khramtsovsky
Выступление Натальи Александровны Храмцовской, ведущего эксперта по управлению документацией ООО «Электронные офисные системы», к.и.н. с докладом «Законодательство и оценка рисков при автоматизации работы с документами. Вызовы для организаций» рамках Дня Автоматизации работы с документами (Administrative) на Форуме RAW 2016 «Неделя автоматизации бизнес-процессов, 22 сентября 2016 года
Doing more with less resources used to be a situation common just for academic scientists. This is unfortunately still true for academics but we are seeing others facing many of the same challenges. With the squeeze on budgets and cost cutting resulting from recent worldwide economic challenges, the failure of many drugs to make it through the pipeline to the market, and the increasing costs associated with the drug development process, we are now seeing in the pharmaceutical industry a dramatic shift, perhaps belatedly, to have to accommodate similar challenges of doing more with less
Univ of Miami CTSI: Citizen science seminar; Oct 2014Richard Bookman
The University of Miami's Clinical & Translational Science Institute runs a seminar course for MS students.
This talk surveys 8 citizen science projects, reviews NIH's current activities, and identifies issues for attention, particularly with ethical, legal and social implications.
Improving health care outcomes with responsible data scienceWessel Kraaij
Keynote presentation by Wessel Kraaij at the Dutch pattern recognition and impage processing society (NVPBV) 29/5/2018, Eindhoven.
This talk discusses
1. trends in health care and respondible data science and their intersection
2. Secure federated analytics on distributed data repositories
3. Generating clinically relevant hypotheses from patient forum discussions.
Presentation about OHSL's new initiative, Mycroft Cognitive Assistant®, which is intended to streamline the operational aspects of research using IBM Watson cognitive computing capabilities.
The slide presentation that preceded of the annual Health Datapalooza in Washington DC, PCORI was pleased to participate in the latest installment in the Health Data Consortium and PricewaterhouseCoopers (PwC) Innovators in Health Data Series, a webinar featuring PCORI Executive Director Joe Selby, MD, MPH; NIH Director and PCORI Board of Governors member Francis Collins, MD, PhD; and Philip Bourne, PhD, NIH’s Associate Director for Data Science.
From Research to Practice - New Models for Data-sharing and Collaboration to ...Health Data Consortium
Watch the webinar here: http://encore.meetingbridge.com/MB005418/140528/
Webinar transcript: http://hdc.membershipsoftware.org/Files/webinars/HDC-PwC%20NIH%20&%20PCORI%20Webinar%20Transcript%205_28_14.pdf
Patient-Centered Outcomes Research Institute (PCORI) Executive Director Joe Selby, MD, MPH; National Institutes of Health (NIH) Director and PCORI Board of Governors member Francis Collins, MD, PhD; and NIH Associate Director for Data Science Philip Bourne, PhD discussed new and emerging trends in big data for health, including:
- How researchers, patients, clinicians, and others are forging new models for data-sharing.
- Leveraging the quantity, variety, and analytic potential of health-related data for research and practice.
- Addressing patients’ perspectives, needs, and concerns in creating new opportunities for innovation and translational science.
- Exciting initiatives such as PCORnet, the National Patient-Centered Clinical Research Network initiative that PCORI is now helping to develop, and related open data and technology efforts such - as the NIH Health Systems Collaboratory and Big Data to Knowledge (BD2K) initiative.
Discover more health data resources on our website at http://www.healthdataconsortium.org/
This presentation outlines a mechanism for using the power of "Big Data", social networking and technology infrastructure to speed the process of curing a horrible disease.
MseqDR consortium: a grass-roots effort to establish a global resource aimed ...Human Variome Project
The success of whole exome sequencing (WES) for highly heterogeneous disorders, such as mitochondrial disease, is limited by substantial technical and bioinformatics challenges to correctly identify and prioritize the extensive number of sequence variants present in each patient. The likelihood of success can be greatly improved if a large cohort of patient data is assembled in which sequence variants can be systematically analysed, annotated, and interpreted relative to known phenotype. This effort has engaged and united more than 100 international mitochondrial clinicians, researchers, and bioinformaticians in the Mitochondrial Disease Sequence Data Resource (MSeqDR) consortium that formed in June 2012 to identify and prioritize the specific WES data analysis needs of the global mitochondrial disease community. Through regular web-based meetings, we have familiarized ourselves with existing strengths and gaps facing integration of MSeqDR with public resources, as well as the major practical, technical, and ethical challenges that must be overcome to create a sustainable data resource. We have now moved forward toward our common goal by establishing a central data resource (http://mseqdr.org/) that has both public access and secure web-based features that allow the coherent compilation, organization, annotation, and analysis of WES and mtDNA genome data sets generated in both clinical- and research-based settings of suspected mitochondrial disease patients. The most important aims of the MSeqDR consortium are summarized in the MSeqDR portal within the Consortium overview sections. Consortium participants are organized in 3 working groups that include (1) Technology and Bioinformatics; (2) Phenotyping, databasing, IRB concerns and access; and (3) Mitochondrial DNA specific concerns. The online MSeqDR resource is organized into discrete sections to facilitate data deposition and common reannotation, data visualization, data set mining, and access management. With the support of the United Mitochondrial Disease Foundation (UMDF) and the NINDS/NICHD U54 supported North American Mitochondrial Disease Consortium (NAMDC), the MSeqDR prototype has been built. Current major components include common data upload and reannotation using a novel HBCR based annotation tool that has also been made publicly available through the website, MSeqDR GBrowse that allows ready visualization of all public and MSeqDR specific data including labspecific aggregate data visualization tracks, MSeqDR-LSDB instance of nearly 1250 mitochondrial disease and mitochodnrial localized genes that is based on the Locus Specific Database model, exome data set mining in individuals or families using the GEM.app tool, and Account & Access Management. Within MSeqDR GBrowse it is now possible to explore data derived from MitoMap, HmtDB, ClinVar, UCSC-NumtS, ENCODE, 1000 genomes, and many other resources that bioinformaticians recruited to the project are organizing.
Thesis Proposal, as presented for dissertation proposal defenseHeather Piwowar
The slides I presented for my PhD proposal defense for my project, "Foundational studies for measuring the impact, prevalence, and patterns of publicly sharing biomedical research data." Dept of Biomedical Informatics, University of Pittsburgh.
Similar to 20160811 Big Data for Health and Medicine (20)
Professional air quality monitoring systems provide immediate, on-site data for analysis, compliance, and decision-making.
Monitor common gases, weather parameters, particulates.
This pdf is about the Schizophrenia.
For more details visit on YouTube; @SELF-EXPLANATORY;
https://www.youtube.com/channel/UCAiarMZDNhe1A3Rnpr_WkzA/videos
Thanks...!
Seminar of U.V. Spectroscopy by SAMIR PANDASAMIR PANDA
Spectroscopy is a branch of science dealing the study of interaction of electromagnetic radiation with matter.
Ultraviolet-visible spectroscopy refers to absorption spectroscopy or reflect spectroscopy in the UV-VIS spectral region.
Ultraviolet-visible spectroscopy is an analytical method that can measure the amount of light received by the analyte.
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.Sérgio Sacani
The return of a sample of near-surface atmosphere from Mars would facilitate answers to several first-order science questions surrounding the formation and evolution of the planet. One of the important aspects of terrestrial planet formation in general is the role that primary atmospheres played in influencing the chemistry and structure of the planets and their antecedents. Studies of the martian atmosphere can be used to investigate the role of a primary atmosphere in its history. Atmosphere samples would also inform our understanding of the near-surface chemistry of the planet, and ultimately the prospects for life. High-precision isotopic analyses of constituent gases are needed to address these questions, requiring that the analyses are made on returned samples rather than in situ.
Slide 1: Title Slide
Extrachromosomal Inheritance
Slide 2: Introduction to Extrachromosomal Inheritance
Definition: Extrachromosomal inheritance refers to the transmission of genetic material that is not found within the nucleus.
Key Components: Involves genes located in mitochondria, chloroplasts, and plasmids.
Slide 3: Mitochondrial Inheritance
Mitochondria: Organelles responsible for energy production.
Mitochondrial DNA (mtDNA): Circular DNA molecule found in mitochondria.
Inheritance Pattern: Maternally inherited, meaning it is passed from mothers to all their offspring.
Diseases: Examples include Leber’s hereditary optic neuropathy (LHON) and mitochondrial myopathy.
Slide 4: Chloroplast Inheritance
Chloroplasts: Organelles responsible for photosynthesis in plants.
Chloroplast DNA (cpDNA): Circular DNA molecule found in chloroplasts.
Inheritance Pattern: Often maternally inherited in most plants, but can vary in some species.
Examples: Variegation in plants, where leaf color patterns are determined by chloroplast DNA.
Slide 5: Plasmid Inheritance
Plasmids: Small, circular DNA molecules found in bacteria and some eukaryotes.
Features: Can carry antibiotic resistance genes and can be transferred between cells through processes like conjugation.
Significance: Important in biotechnology for gene cloning and genetic engineering.
Slide 6: Mechanisms of Extrachromosomal Inheritance
Non-Mendelian Patterns: Do not follow Mendel’s laws of inheritance.
Cytoplasmic Segregation: During cell division, organelles like mitochondria and chloroplasts are randomly distributed to daughter cells.
Heteroplasmy: Presence of more than one type of organellar genome within a cell, leading to variation in expression.
Slide 7: Examples of Extrachromosomal Inheritance
Four O’clock Plant (Mirabilis jalapa): Shows variegated leaves due to different cpDNA in leaf cells.
Petite Mutants in Yeast: Result from mutations in mitochondrial DNA affecting respiration.
Slide 8: Importance of Extrachromosomal Inheritance
Evolution: Provides insight into the evolution of eukaryotic cells.
Medicine: Understanding mitochondrial inheritance helps in diagnosing and treating mitochondrial diseases.
Agriculture: Chloroplast inheritance can be used in plant breeding and genetic modification.
Slide 9: Recent Research and Advances
Gene Editing: Techniques like CRISPR-Cas9 are being used to edit mitochondrial and chloroplast DNA.
Therapies: Development of mitochondrial replacement therapy (MRT) for preventing mitochondrial diseases.
Slide 10: Conclusion
Summary: Extrachromosomal inheritance involves the transmission of genetic material outside the nucleus and plays a crucial role in genetics, medicine, and biotechnology.
Future Directions: Continued research and technological advancements hold promise for new treatments and applications.
Slide 11: Questions and Discussion
Invite Audience: Open the floor for any questions or further discussion on the topic.
Introduction:
RNA interference (RNAi) or Post-Transcriptional Gene Silencing (PTGS) is an important biological process for modulating eukaryotic gene expression.
It is highly conserved process of posttranscriptional gene silencing by which double stranded RNA (dsRNA) causes sequence-specific degradation of mRNA sequences.
dsRNA-induced gene silencing (RNAi) is reported in a wide range of eukaryotes ranging from worms, insects, mammals and plants.
This process mediates resistance to both endogenous parasitic and exogenous pathogenic nucleic acids, and regulates the expression of protein-coding genes.
What are small ncRNAs?
micro RNA (miRNA)
short interfering RNA (siRNA)
Properties of small non-coding RNA:
Involved in silencing mRNA transcripts.
Called “small” because they are usually only about 21-24 nucleotides long.
Synthesized by first cutting up longer precursor sequences (like the 61nt one that Lee discovered).
Silence an mRNA by base pairing with some sequence on the mRNA.
Discovery of siRNA?
The first small RNA:
In 1993 Rosalind Lee (Victor Ambros lab) was studying a non- coding gene in C. elegans, lin-4, that was involved in silencing of another gene, lin-14, at the appropriate time in the
development of the worm C. elegans.
Two small transcripts of lin-4 (22nt and 61nt) were found to be complementary to a sequence in the 3' UTR of lin-14.
Because lin-4 encoded no protein, she deduced that it must be these transcripts that are causing the silencing by RNA-RNA interactions.
Types of RNAi ( non coding RNA)
MiRNA
Length (23-25 nt)
Trans acting
Binds with target MRNA in mismatch
Translation inhibition
Si RNA
Length 21 nt.
Cis acting
Bind with target Mrna in perfect complementary sequence
Piwi-RNA
Length ; 25 to 36 nt.
Expressed in Germ Cells
Regulates trnasposomes activity
MECHANISM OF RNAI:
First the double-stranded RNA teams up with a protein complex named Dicer, which cuts the long RNA into short pieces.
Then another protein complex called RISC (RNA-induced silencing complex) discards one of the two RNA strands.
The RISC-docked, single-stranded RNA then pairs with the homologous mRNA and destroys it.
THE RISC COMPLEX:
RISC is large(>500kD) RNA multi- protein Binding complex which triggers MRNA degradation in response to MRNA
Unwinding of double stranded Si RNA by ATP independent Helicase
Active component of RISC is Ago proteins( ENDONUCLEASE) which cleave target MRNA.
DICER: endonuclease (RNase Family III)
Argonaute: Central Component of the RNA-Induced Silencing Complex (RISC)
One strand of the dsRNA produced by Dicer is retained in the RISC complex in association with Argonaute
ARGONAUTE PROTEIN :
1.PAZ(PIWI/Argonaute/ Zwille)- Recognition of target MRNA
2.PIWI (p-element induced wimpy Testis)- breaks Phosphodiester bond of mRNA.)RNAse H activity.
MiRNA:
The Double-stranded RNAs are naturally produced in eukaryotic cells during development, and they have a key role in regulating gene expression .
1. brian m. bot | principal scientist |
2016 aug 11
sage bionetworks
big data for health and medicine
biomedical research in an
increasingly digital world
| @BrianMBot
university of nebraska at omaha
12. “Scientists often study the past as
obsessively as historians because few
other professions depend so acutely on it.
Every experiment is a conversation with
a prior experiment,
every new theory a refutation of the old”
-Siddhartha Mukherjee, The Emperor of All Maladies
14. sage bionetworks
promote open systems, incentives, and norms
to redefine how complex biological data is
gathered, shared, and used
our approach
15. sage bionetworks
engage diverse communities of researchers
around biological and analytical problems
too complex for a single institution
our focus
empower citizens to track their own health
and contribute deep phenotypic data to
research topics important to them
31. sage bionetworks
engage diverse communities of researchers
around biological and analytical problems
too complex for a single institution
our focus
empower citizens to track their own health
and contribute deep phenotypic data to
research topics important to them
35. nearly 200 million smart phone users in US
insular health trackingmove beyond
36. insular health trackingmove beyond
Stephen Lam / Getty
Tech giants moving
into health may widen
inequalities and harm
research, unless
people can access
and share their data,
warn John T. Wilbanks
and Eric J. Topol.
(but be careful)
20 july 2016
59. mPower six month data release
9,520 unique participants
8,320 completed at least one task
198,639 total activities and surveys completed
1,087 self reported parkinson diagnosis
60. mPower six month data release
task name
type of task and
schedule
unique
participants
unique tasks
demographics survey - once 6,805 6,805
MDS-UPDRS survey - monthly 2,024 2,305
PDQ8 survey - monthly 1,334 1,641
memory activity - t.i.d. 968 8,569
tapping activity - t.i.d. 8,003 78,887
voice activity - t.i.d. 5,826 65,022
walking activity - t.i.d. 3,101 35,410
63. Parkinson’s Disease Foundation
Eli Lilly
AstraZeneca
Apple
Verily
Intel
Infocepts
Posit Science
MIT
The Ohio State University
University of Otago
University of Texas Health Science Center
Istanbul Sehir University
University of Iowa
University of Virginia
University of Toronto
Johns Hopkins University
Vanderbilt University
University of Rochester
McGill University
Xi'an Jiaotong University
University of Washington
Harvard University
mHealth research communityParkinson
69. promote an ecosystem where
research is conducted
for others to consume
…
A second concern held by some is that a
new class of research person will emerge —
people who had nothing to do with the
design and execution of the study but use
another group’s data for their own ends,
possibly stealing from the research
productivity planned by the data gatherers,
or even use the data to try to disprove what
the original investigators had posited.
70. promote an ecosystem where
research is conducted
for others to consume
…
…
There is concern among some front-
line researchers that the system will
be taken over by what some
researchers have characterized as
“research parasites”research parasites
71. promote an ecosystem where
research is conducted
for others to consume
…
…
research parasites
…
…
74. mHealth research community
Sage Bionetworks joins The Scripps Research Institute (TSRI) for
PMI Cohort Program via Participant Technology Center (PTC)
06 July 2016
75. mHealth research community
Sage Bionetworks joins The Scripps Research
Institute (TSRI) for PMI Cohort Program via
Participant Technology Center (PTC)
In collaboration with Scripps Participant Technologies Center (PTC):
• Sage Bionetworks will be responsible for the patient consent and
data governance, as well as the community outreach and
participant engagement efforts of the PTC
• Sage Bionetworks will also be engaged in the scientific and
engineering work to develop new methodologies for measuring
symptoms of health and disease, including developing symptom
measurements for phone, wearable, and other sensors